S&P 500   3,090.72 (-0.04%)
DOW   27,748.84 (+0.21%)
QQQ   201.09 (-0.22%)
CGC   18.61 (-3.33%)
BABA   181.60 (-2.87%)
GE   11.24 (-1.66%)
T   39.10 (-0.20%)
F   8.82 (-2.43%)
ACB   3.52 (-1.40%)
DIS   146.57 (+5.77%)
S&P 500   3,090.72 (-0.04%)
DOW   27,748.84 (+0.21%)
QQQ   201.09 (-0.22%)
CGC   18.61 (-3.33%)
BABA   181.60 (-2.87%)
GE   11.24 (-1.66%)
T   39.10 (-0.20%)
F   8.82 (-2.43%)
ACB   3.52 (-1.40%)
DIS   146.57 (+5.77%)
S&P 500   3,090.72 (-0.04%)
DOW   27,748.84 (+0.21%)
QQQ   201.09 (-0.22%)
CGC   18.61 (-3.33%)
BABA   181.60 (-2.87%)
GE   11.24 (-1.66%)
T   39.10 (-0.20%)
F   8.82 (-2.43%)
ACB   3.52 (-1.40%)
DIS   146.57 (+5.77%)
S&P 500   3,090.72 (-0.04%)
DOW   27,748.84 (+0.21%)
QQQ   201.09 (-0.22%)
CGC   18.61 (-3.33%)
BABA   181.60 (-2.87%)
GE   11.24 (-1.66%)
T   39.10 (-0.20%)
F   8.82 (-2.43%)
ACB   3.52 (-1.40%)
DIS   146.57 (+5.77%)
Log in

Ampio Pharmaceuticals Stock Price, Forecast & Analysis (NYSEAMERICAN:AMPE)

$0.36
0.00 (0.00 %)
(As of 11/13/2019 02:39 PM ET)
Today's Range
$0.35
Now: $0.36
$0.37
50-Day Range N/A
52-Week Range
$0.26
Now: $0.36
$1.31
Volume317,050 shs
Average Volume785,243 shs
Market Capitalization$56.37 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee. Read More…

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Biotechnology
Sub-IndustryPharmaceuticals
SectorMedical
Current SymbolNYSEAMERICAN:AMPE
CUSIP03209T10
Phone+1-720-4376500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees22
Market Cap$56.37 million
Next Earnings Date3/16/2020 (Estimated)
OptionableOptionable

Receive AMPE News and Ratings via Email

Sign-up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter.


Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Frequently Asked Questions

What is Ampio Pharmaceuticals' stock symbol?

Ampio Pharmaceuticals trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "AMPE."

How were Ampio Pharmaceuticals' earnings last quarter?

Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) issued its quarterly earnings results on Thursday, November, 7th. The specialty pharmaceutical company reported ($0.05) earnings per share (EPS) for the quarter. View Ampio Pharmaceuticals' Earnings History.

When is Ampio Pharmaceuticals' next earnings date?

Ampio Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Ampio Pharmaceuticals.

Has Ampio Pharmaceuticals been receiving favorable news coverage?

News coverage about AMPE stock has trended very negative on Wednesday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Ampio Pharmaceuticals earned a news sentiment score of -3.2 on InfoTrie's scale. They also assigned press coverage about the specialty pharmaceutical company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Ampio Pharmaceuticals.

Who are some of Ampio Pharmaceuticals' key competitors?

What other stocks do shareholders of Ampio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Trevena (TRVN), Cerus (CERS), NovaBay Pharmaceuticals (NBY), Rigel Pharmaceuticals (RIGL), Synergy Pharmaceuticals (SGYP), AVEO Pharmaceuticals (AVEO), ImmunoGen (IMGN), Madrigal Pharmaceuticals (MDGL), NVIDIA (nvda) and AcelRx Pharmaceuticals (ACRX).

Who are Ampio Pharmaceuticals' key executives?

Ampio Pharmaceuticals' management team includes the folowing people:
  • Mr. Michael E. Macaluso, Founder, Chairman & CEO (Age 67)
  • Mr. Thomas E. Chilcott III, CFO, Treasurer & Sec. (Age 51)
  • Ms. Holli Cherevka, Chief Operating Officer (Age 36)

Who are Ampio Pharmaceuticals' major shareholders?

Ampio Pharmaceuticals' stock is owned by a number of of retail and institutional investors. Top institutional investors include Wedbush Securities Inc. (0.07%). View Institutional Ownership Trends for Ampio Pharmaceuticals.

Which institutional investors are selling Ampio Pharmaceuticals stock?

AMPE stock was sold by a variety of institutional investors in the last quarter, including Wedbush Securities Inc.. View Insider Buying and Selling for Ampio Pharmaceuticals.

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Ampio Pharmaceuticals' stock price today?

One share of AMPE stock can currently be purchased for approximately $0.34.

How big of a company is Ampio Pharmaceuticals?

Ampio Pharmaceuticals has a market capitalization of $53.94 million. Ampio Pharmaceuticals employs 22 workers across the globe.View Additional Information About Ampio Pharmaceuticals.

What is Ampio Pharmaceuticals' official website?

The official website for Ampio Pharmaceuticals is http://ampiopharma.com/.

How can I contact Ampio Pharmaceuticals?

Ampio Pharmaceuticals' mailing address is 373 Inverness Pkwy Ste 200, ENGLEWOOD, CO 80112-5898, United States. The specialty pharmaceutical company can be reached via phone at +1-720-4376500.


MarketBeat Community Rating for Ampio Pharmaceuticals (NYSEAMERICAN AMPE)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  142 (Vote Outperform)
Underperform Votes:  145 (Vote Underperform)
Total Votes:  287
MarketBeat's community ratings are surveys of what our community members think about Ampio Pharmaceuticals and other stocks. Vote "Outperform" if you believe AMPE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMPE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel